Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tuberculosis as a Risk Factor for a Severe Course and Adverse Long-term Outcome of a Symptomatic Sars-CoV-2 Infection in Johannesburg, South Africa

NCT05643781 is registered in ClinicalTrials.gov with The Aurum Institute NPC as lead sponsor.

NCT NCT05643781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tuberculosis as a Risk Factor for a Severe Course and Adverse Long-term Outcome of a Symptomatic Sars-CoV-2 Infection in Johannesburg, South Africa
Lead sponsor
The Aurum Institute NPC
Phase
Observational
Overall status
Completed
Start date
March 23, 2021
Completion date
November 30, 2022
Enrollment
157 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, post-acute covid-19 syndrome, tuberculosis